Solid Biosciences (SLDB) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026)
Solid Biosciences (SLDB) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Solid Biosciences |
789.54 Mn |
408.86 Mn |
- |
-12.69% |
| Date | Value |
|---|
| Mar 31, 2026 |
-12.69% |
| Dec 31, 2025 |
-12.18% |
| Sep 30, 2025 |
-14.03% |
| Jun 30, 2025 |
-20.61% |
| Mar 31, 2025 |
-29.85% |
| Dec 31, 2024 |
-28.34% |
| Sep 30, 2024 |
-28.08% |
| Jun 30, 2024 |
-26.42% |
| Mar 31, 2024 |
-25.75% |
| Dec 31, 2023 |
-31.41% |
| Sep 30, 2023 |
12.43% |
| Jun 30, 2023 |
7.95% |
| Mar 31, 2023 |
41.17% |
| Dec 31, 2022 |
49.44% |
| Sep 30, 2022 |
-9.00% |
| Jun 30, 2022 |
-3.94% |
| Mar 31, 2022 |
-18.28% |
| Dec 31, 2021 |
-20.74% |
| Sep 30, 2021 |
-22.36% |
| Jun 30, 2021 |
-25.61% |
